[{"abstract": "The German drug maker agreed to acquire Merck\u2019s consumer care business for $14.2 billion, gaining control of Claritin, Coppertone and Dr. Scholl\u2019s.", "web_url": "https://dealbook.nytimes.com/2014/05/06/bayer-to-buy-mercks-consumer-care-business-for-14-2-billion/", "snippet": "The German drug maker agreed to acquire Merck\u2019s consumer care business for $14.2 billion, gaining control of Claritin, Coppertone and Dr. Scholl\u2019s.", "lead_paragraph": "Updated, 12:06 p.m. | LONDON \u2014 The German drug maker Bayer said on Tuesday that it had agreed to acquire Merck\u2019s consumer care business for $14.2 billion, a deal that will make Bayer one of the largest providers of over-the-counter products.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "Bayer Deal to Expand Consumer Business With Merck Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "Bayer Deal to Expand Consumer Business", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "persons", "value": "Dekkers, Marijn E", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Bayer AG", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 5, "major": "N"}], "pub_date": "2014-05-06T10:43:04+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chad Bray and Katie Thomas", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}, {"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 2}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/267536e1-6711-52b7-ab71-ec58b69cafad", "word_count": 709, "uri": "nyt://article/267536e1-6711-52b7-ab71-ec58b69cafad"}, {"abstract": "Bayer\u2019s $14.2 billion acquisition of Merck\u2019s consumer care business makes strategic sense and sizable tax breaks will help, writes Olaf Storbeck of Reuters Breakingviews.", "web_url": "https://dealbook.nytimes.com/2014/05/06/how-bayers-buy-makes-sense/", "snippet": "Bayer\u2019s $14.2 billion acquisition of Merck\u2019s consumer care business makes strategic sense and sizable tax breaks will help, writes Olaf Storbeck of Reuters Breakingviews.", "lead_paragraph": "Bayer\u2019s $14.2 billion acquisition of Merck\u2019s consumer care business is less pricey than it looks.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-articleLarge.jpg", "height": 365, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 365}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-jumbo.jpg", "height": 622, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-superJumbo.jpg", "height": 1244, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/07/business/dbpix-bayer2/dbpix-bayer2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "How Bayer\u2019s Buy Makes Sense", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "subject", "value": "Tax Credits, Deductions and Exemptions", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Bayer AG", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 5, "major": "N"}], "pub_date": "2014-05-06T20:10:24+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Olaf Storbeck", "person": [{"firstname": "Olaf", "middlename": null, "lastname": "Storbeck", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/ace912f3-f982-51bf-826d-67f3073c7b64", "word_count": 364, "uri": "nyt://article/ace912f3-f982-51bf-826d-67f3073c7b64"}]